Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Recruiting1
Terminated1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting125%
terminated125%
completed125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

NCT05916469
unknownnot_applicable

Stopping Heavy Periods Project

NCT02002260
completednot_applicable

Levonorgestrel Intrauterine System and Adenomyosis

NCT03104309
terminated

A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35

NCT00161226

Clinical Trials (4)

Showing 4 of 4 trials
NCT05916469

Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study

Recruiting
NCT02002260Not Applicable

Stopping Heavy Periods Project

Unknown
NCT03104309Not Applicable

Levonorgestrel Intrauterine System and Adenomyosis

Completed
NCT00161226

A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35

Terminated

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4